Home
Productsindex
Gene
BioActive Proteinsindex
BioActive Biomarker Proteinslists
BioActive Human Di-SUMO2 Wild-type Chains Protein
SGRP-4797
BioActive Human Di-SUMO2 Wild-type Chains Protein
Source:E. coli-derived Recombinant Human Di-SUMO2 Wild-type Chains Protein
Alternative Names:Smt3A, SUMO3, SMT3B, HSMT3, SMT3H2, small ubiquitin-like modifier 2
SKU:SGRP-4797Biotin
Product Name:BioActive Human Di-SUMO2 Wild-type Chains Protein[Biotin Conjugation]
Product Description:
SKU:SGRP-4797FITC
Product Name:BioActive Human Di-SUMO2 Wild-type Chains Protein[FITC Conjugation]
Product Description:
SKU:SGRP-4797APC
Product Name:BioActive Human Di-SUMO2 Wild-type Chains Protein[APC Conjugation]
Product Description:
SKU:SGRP-4797PE
Product Name:BioActive Human Di-SUMO2 Wild-type Chains Protein[PE Conjugation]
Product Description:
SKU:SGRP-4797Biotin
Product Name:BioActive Human Di-SUMO2 Wild-type Chains Protein[Biotin Conjugation]
Product Description:
SKU:SGRP-4797FITC
Product Name:BioActive Human Di-SUMO2 Wild-type Chains Protein[FITC Conjugation]
Product Description:
SKU:SGRP-4797APC
Product Name:BioActive Human Di-SUMO2 Wild-type Chains Protein[APC Conjugation]
Product Description:
SKU:SGRP-4797PE
Product Name:BioActive Human Di-SUMO2 Wild-type Chains Protein[PE Conjugation]
Product Description:
PROPERTIES
Biological Activity:
The function of SUMO chains is an area of intense research. K11-linked di-SUMO2 WT Chains are ideal for investigating SUMO-binding proteins and as substrates for SUMO-specific proteases. Reaction conditions will need to be optimized for each specific
Purity:
>95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain
Endotoxin Level:
< 0.10 EU per 1 μg of the protein by the LAL method.
Expression System:
E. coli
Format:
Supplied as a solution in HEPES, NaCl and DTT
Species:
Human
Actual MW:
Theoretical Molecular Weight: 21 kDa
Form:
Recombinant
Concentration:
N.A
Stability and Storage:
A minimum of 12 months when stored at ≤ -20 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, ≤ -20 °C under sterile conditions after reconstitution.
Reconstitution:
Reconstitute at 100-500 μg/mL in sterile PBS.
Related Categories
BioActive Biomarker Proteins
Background

Gene Accession

A7XYQ1

Gene Alias

Sine oculis-binding protein homolog, Smt3A, SUMO3, SMT3B, HSMT3, SMT3H2, small ubiquitin-like modifier 2

Background

Implicated in development of the cochlea

RECOMMENDED PRODUCTS
BioActive Human ABL1 (V299L,T315A,F317L,F317V,F317I,F317C) Recombinant Protein,Fc Tag
ABL1

SGRP00624

BioActive Human ABL1 (V299L,T315A,F317L,F317V,F317I,F317C) Recombinant Protein,Fc Tag
View Price and Availability
BioActive Human ABL1 (T315A,F317L,F317V,F317I,F317C,V299L) Recombinant Protein,Fc Tag
ABL1

SGRP00628

BioActive Human ABL1 (T315A,F317L,F317V,F317I,F317C,V299L) Recombinant Protein,Fc Tag
View Price and Availability
BioActive Human AKT1 (Q79K,E17K) Recombinant Protein,Fc Tag
AKT1

SGRP00630

BioActive Human AKT1 (Q79K,E17K) Recombinant Protein,Fc Tag
View Price and Availability
BioActive Human AKT1 (H238Y) Recombinant Protein,Fc Tag
AKT1

SGRP00631

BioActive Human AKT1 (H238Y) Recombinant Protein,Fc Tag
View Price and Availability
BioActive Human ALK (G1123S) Recombinant Protein,Fc Tag
ALK

SGRP00637

BioActive Human ALK (G1123S) Recombinant Protein,Fc Tag
View Price and Availability
0.175331s